Want to Calculate Fair Value?
Enter Stock | Calculate Fair Value
Stock: INCY
Book Value Per Share: $18.93
EPS: $5.72
Diluted EPS TTM: $0.21
Dividend Per Share: None
Dividend Yield: 0.00 %
Dividend Payout Ratio: 0%
Price To Sales Ratio TTM: 3.014
Price To Book Ratio: 3.627
PEG Ratio: 0.123
EV To EBITDA: 26.88
P/E Ratio: 327.24
Forward P/E Ratio: 11.81
Ex Dividend Date: None
Dividend Date: None
Current Price: $68.25
Previous Close: $69.98
52 Week Low: $53.56
52 Week High: $83.95
Earning Date (within 30 days): 2025-07-28
50 Day MA: $65.57
200 Day MA: $68.01
Link to Yahoo (Financial): INCY

Advertisement
 
* Note: Prices are in Million (M) USD.
Description:
Incyte Corporation (INCY) ↓
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $1,688 M
Debt : $34 M
EBITDA : $303 M

Since Cash is greater than Total Debt, 5 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Biotechnology

Based on industry, 5 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 11.93

Since Forward PE Ratio is less than 15, 5 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $413 M
Average Revenue: $1,297 M
Revenue Converted To Free Cash FLow(%): 32%
Avg Free Cash Flow Growth Per Year (Last 5 Years): 19.13%

Since Free Cash Flow (FCF) to Revenue percentage is greater than 25, 5 points assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $4,241 M
Revenue 4 Years Ago (2020-12-31): $2,667 M
Last 5 Years Average Revenue Growth: 12%

Since Revenue Growth is between 10 - 15, 3 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $211 M
Share Count 5 Years Ago (2020-12-31): $218 M

Company is buying back its own shares, 3 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $6.74
Trailing 12-Month Earnings Per Share (EPS): $4.70
Average Earnings Per Share (EPS): $5.72
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%

Since Dividend Per Share is less than or equal to 0, 0 point assigned.

Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: 7%

Since Average ROE is less than 10, 1 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $68
52-Week Low: $54
Threshold Price (15% Above 52-Week Low): $62

Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $13,302 M

Since Market Cap is between 10B - 100B, 2 points assigned.
% Exposure to Total Portfolio
Based on the calculated score, we recommend do not exceed 3% exposure of Total Portfolio.
Value-Trade has assigned 29 points to above Incyte Corporation (INCY) stock.
Last 8 Years Avg PE (Limited to last 8 years of EPS data) 26, Fair Value PE 25, Industry Based PE is 20 and Growth based PE is 10. Based on these all values average assigned is 20.25.
Value-Trades has assined P/E value 20.25. Since an average (Current Year EPS + Next Year EPS) earning per share is $5.72.
The fair value of Incyte Corporation (INCY) stock should be (20.25 x $5.72) = $115.83

Share this valuation:



Advertisement

Advertisement